Journey Medical (DERM) Competitors $7.23 -0.22 (-2.95%) Closing price 04:00 PM EasternExtended Trading$7.20 -0.04 (-0.48%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock DERM vs. FBIO, GHRS, TBPH, PROK, VIR, KURA, KALV, MNMD, TYRA, and ORGOShould you be buying Journey Medical stock or one of its competitors? The main competitors of Journey Medical include Fortress Biotech (FBIO), GH Research (GHRS), Theravance Biopharma (TBPH), ProKidney (PROK), Vir Biotechnology (VIR), Kura Oncology (KURA), KalVista Pharmaceuticals (KALV), Mind Medicine (MindMed) (MNMD), Tyra Biosciences (TYRA), and Organogenesis (ORGO). These companies are all part of the "medical" sector. Journey Medical vs. Its Competitors Fortress Biotech GH Research Theravance Biopharma ProKidney Vir Biotechnology Kura Oncology KalVista Pharmaceuticals Mind Medicine (MindMed) Tyra Biosciences Organogenesis Journey Medical (NASDAQ:DERM) and Fortress Biotech (NASDAQ:FBIO) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends, media sentiment and earnings. Which has better earnings & valuation, DERM or FBIO? Journey Medical has higher earnings, but lower revenue than Fortress Biotech. Journey Medical is trading at a lower price-to-earnings ratio than Fortress Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioJourney Medical$56.40M3.37-$14.67M-$0.38-19.03Fortress Biotech$57.67M1.99-$46M-$1.05-3.68 Which has more volatility & risk, DERM or FBIO? Journey Medical has a beta of 0.8, meaning that its share price is 20% less volatile than the S&P 500. Comparatively, Fortress Biotech has a beta of 1.61, meaning that its share price is 61% more volatile than the S&P 500. Do insiders & institutionals have more ownership in DERM or FBIO? 7.3% of Journey Medical shares are held by institutional investors. Comparatively, 96.5% of Fortress Biotech shares are held by institutional investors. 15.0% of Journey Medical shares are held by insiders. Comparatively, 27.9% of Fortress Biotech shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Do analysts rate DERM or FBIO? Journey Medical currently has a consensus price target of $12.17, suggesting a potential upside of 68.28%. Fortress Biotech has a consensus price target of $16.50, suggesting a potential upside of 327.46%. Given Fortress Biotech's stronger consensus rating and higher probable upside, analysts plainly believe Fortress Biotech is more favorable than Journey Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Journey Medical 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50Fortress Biotech 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media prefer DERM or FBIO? In the previous week, Journey Medical and Journey Medical both had 2 articles in the media. Fortress Biotech's average media sentiment score of 0.94 beat Journey Medical's score of -0.15 indicating that Fortress Biotech is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Journey Medical 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Fortress Biotech 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is DERM or FBIO more profitable? Journey Medical has a net margin of -15.49% compared to Fortress Biotech's net margin of -24.84%. Journey Medical's return on equity of -48.69% beat Fortress Biotech's return on equity.Company Net Margins Return on Equity Return on Assets Journey Medical-15.49% -48.69% -11.26% Fortress Biotech -24.84%-301.81%-27.48% SummaryFortress Biotech beats Journey Medical on 8 of the 15 factors compared between the two stocks. Get Journey Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for DERM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DERM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DERM vs. The Competition Export to ExcelMetricJourney MedicalMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$190.22M$2.64B$5.78B$10.04BDividend YieldN/A49.23%5.27%4.52%P/E Ratio-19.0323.7475.5726.08Price / Sales3.37501.55516.51171.66Price / CashN/A167.9837.2059.76Price / Book7.955.2711.536.20Net Income-$14.67M$32.95M$3.29B$270.65M7 Day Performance4.03%1.34%0.44%2.77%1 Month Performance-4.49%30.71%10.84%8.83%1 Year Performance51.89%2.03%61.62%27.49% Journey Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DERMJourney Medical1.8558 of 5 stars$7.23-3.0%$12.17+68.3%+54.2%$190.22M$56.40M-19.0390FBIOFortress Biotech3.0304 of 5 stars$2.58+6.6%$16.50+539.5%+101.7%$76.77M$57.67M-2.46170High Trading VolumeGHRSGH Research2.0312 of 5 stars$13.50-2.5%$32.00+137.0%+57.9%$702.38MN/A-18.2410Positive NewsTBPHTheravance Biopharma3.7526 of 5 stars$13.88-0.6%$21.33+53.7%+72.0%$699.02M$64.38M57.83110Positive NewsPROKProKidney3.2293 of 5 stars$2.36-5.6%$6.25+164.8%-7.5%$694.51M$80K-4.143VIRVir Biotechnology3.3046 of 5 stars$4.94-2.0%$28.44+475.8%-33.0%$686.25M$74.21M-1.24580KURAKura Oncology4.2803 of 5 stars$7.90-2.1%$24.10+205.1%-59.0%$685.70M$53.88M-3.50130News CoverageInsider TradeGap UpKALVKalVista Pharmaceuticals3.9791 of 5 stars$13.46-0.4%$26.29+95.3%+31.5%$677.57MN/A-3.65100Insider TradeMNMDMind Medicine (MindMed)2.2686 of 5 stars$8.88-9.2%$24.71+178.3%+62.6%$675.66MN/A-5.8040Positive NewsTYRATyra Biosciences2.8472 of 5 stars$12.67+2.4%$30.83+143.4%-45.0%$675.28MN/A-7.1220Positive NewsAnalyst ForecastGap UpORGOOrganogenesis3.9774 of 5 stars$5.15+0.6%$7.50+45.6%+92.5%$653.32M$482.04M-36.78950News CoveragePositive NewsGap Down Related Companies and Tools Related Companies Fortress Biotech Competitors GH Research Competitors Theravance Biopharma Competitors ProKidney Competitors Vir Biotechnology Competitors Kura Oncology Competitors KalVista Pharmaceuticals Competitors Mind Medicine (MindMed) Competitors Tyra Biosciences Competitors Organogenesis Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DERM) was last updated on 9/10/2025 by MarketBeat.com Staff From Our PartnersNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredWall Street Legend Issues Urgent AI Stock Warning'Hidden AI' is taking the U.S. stock market by storm.Chaikin Analytics | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Journey Medical Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Journey Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
